Maria Dall'Era, MD (she/her/hers)

Director
UCSF
Corte Madera, CA, United States

I am the Chief of Rheumatology, Director of the Rheumatology Clinical Research Center, clinical researcher, and practicing rheumatologist at the University of California, San Francisco. I lead an integrated clinical and research program devoted to two closely-related goals: (i) to improve our understanding of the molecular and epidemiologic basis for systemic lupus erythematosus (SLE); and (ii) to develop novel approaches for the treatment of SLE.

Presentation(s):

• Disease Modification in SLE-Definition

  Sunday, November 12, 2023
  9:15 AM – 9:30 AM PT

  Disclosure(s): Annexon Biosciences: Consultant (Ongoing), Grant/Research Support (Ongoing); AstraZeneca: Consultant (Ongoing); Aurinia: Consultant (Ongoing); Biogen: Consultant (Ongoing); GlaxoSmithKlein: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer: Consultant (Ongoing)

• 0782: Comparison of Dual-immunosuppressive Therapy with a Voclosporin-based, Triple-immunosuppressive Regimen for Lupus Nephritis in the ALMS and AURORA 1 Studies

  Sunday, November 12, 2023
  2:15 PM – 2:25 PM PT

  Disclosure(s): Annexon Biosciences: Consultant (Ongoing), Grant/Research Support (Ongoing); AstraZeneca: Consultant (Ongoing); Aurinia: Consultant (Ongoing); Biogen: Consultant (Ongoing); GlaxoSmithKlein: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer: Consultant (Ongoing)

• Meet the Panel: The Latest in Lupus Treatment

  Monday, November 13, 2023
  7:30 AM – 8:15 AM PT

  Disclosure(s): Annexon Biosciences: Consultant (Ongoing), Grant/Research Support (Ongoing); AstraZeneca: Consultant (Ongoing); Aurinia: Consultant (Ongoing); Biogen: Consultant (Ongoing); GlaxoSmithKlein: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer: Consultant (Ongoing)

• 14T124: Advancing Non-Invasive Biomarkers in ANCA-Associated Vasculitis and Lupus Nephritis: A Translational State of the Art

  Tuesday, November 14, 2023
  11:00 AM – 12:00 PM PT

  Disclosure(s): Annexon Biosciences: Consultant (Ongoing), Grant/Research Support (Ongoing); AstraZeneca: Consultant (Ongoing); Aurinia: Consultant (Ongoing); Biogen: Consultant (Ongoing); GlaxoSmithKlein: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer: Consultant (Ongoing)